May 30, 2025

June 9, 2025

This week’s newsletter included:

• Rep. Blake Moore Holds Tariff Roundtable
• Rep. Blake Moore Urges Caution on Possible Section 232 Pharma Tariffs
• Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
• UofU Startup, Eyescreen, Receives Funding to Improve Drug Development for Vision Loss
• Halia Therapeutics CEO Dr. David Bearss Delivered Keynote Address at Med Investment Forum 2025 in Abu Dhabi
• The Healthcare Technology Report: The Top 25 Healthcare AI Executives of 2025
• Utah Business Announces 30 Women to Watch 2025
• Considerations for Life Sciences Employers When Planning RIFs
• Seek Labs’ President, Keith Marmer, Transitions to Board of Directors
• First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial
• Teva Reaffirms “Pivot to Growth” Strategy Progress
• Myriad Genetics Highlights New Research Advancements, Oncology Innovations at 2025 ASCO Annual Meeting
• Don’t Miss BioUtah’s Exclusive Biosphere Magazine Promotional Opportunity
• Nominations Now Open: 2025 Innovations in Regulatory Science & Policy Awards
• Utah Business: Nominations for Most Influential Women Open
• Utah Business: Nominations for Innovation Awards Open

Featured New BioUtah Elite Bronze Member: Scientia